![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Identa Corp (QB) | USOTC:IDTA | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.28 | 45.90% | 0.89 | 0.41 | 1.00 | 0.89 | 0.89 | 0.89 | 100 | 18:46:12 |
Mr. Shoham stated, "Things have been happening at a very accelerated pace at Identa Corp and we will be releasing much information concerning the different markets and other issues in the next few weeks and months. We have a lot of information to be disclosed and some of it is related to following up on previous press releases. (such as DOD and name of drug store chain)
The new marketing team in the states will be in the following format:
IDenta's entire product line may be found at www.IDenta.biz and www.IDenta-corp.com
ABOUT IDENTA Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
DISCLAIMER Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, www.identa.biz. www.identa-corp.com
Contact: Yaacov Shoham IDenta Corp. CEO Tel: +972-52-6554487 fpi@drugsdetector.com http://www.identa.biz
1 Year Identa (QB) Chart |
1 Month Identa (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions